SHP Wealth Management
Position in TEVA — Teva Pharmaceutical Industries Ltd
CIK 1807060
PLYMOUTH, MA
Position in TEVA
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$5,522
+$613 QoQ
Shares Held
163
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#598
of 675 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026SHP Wealth Management holds $212,913 across 18 Drug Manufacturers - Specialty & Generic names. TEVA ranks #7 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HIMS |
Hims & Hers Health, Inc.
|
3,233 | $112,088 | |
| 2 | TAK |
Takeda Pharmaceutical Co Ltd
|
2,393 | $38,359 | |
| 3 | ZTS |
Zoetis Inc.
|
213 | $15,306 | |
| 4 | ANIK |
Anika Therapeutics, Inc.
|
681 | $9,963 | |
| 5 | HLN |
Haleon plc
|
913 | $8,518 | |
| 6 | RDY |
Dr Reddys Laboratories Ltd
|
448 | $6,491 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
163 | $5,522 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
25 | $2,773 |
All Filings in TEVA
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,522 | 163 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $4,909 | 163 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $5,399 | 173 | Shares | Sole | 2026-03-04 | |
| No filing history on record for this holder in this stock. | ||||||